BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 17, 2002
View Archived Issues
MedImmune, Corixa Take Cases To FDA Advisory Committees
While The Street is leaning toward a favorable vote for MedImmune Inc.'s FluMist as an intranasal influenza vaccine, it's not so clear whether Seattle-based Corixa Inc. will get the nod for its cancer drug, Bexxar. (BioWord Today)
Read More
CDP 870 Becomes Inhale's 4th PEG Product In Pivotal Trials
Read More
NIH Structural Biologists Dissect AIDS Virus Triple-Threat Infection, Quick Change, Immunity Evasion
Read More
AdipoGenix Lands Deal With J&J For Program In Obesity
Read More
Goodman Named To Replace Zoon As Director Of CBER
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More